Patent · US Active

Engineered glucosyltransferases

US10774315B2 · kind B2 · utility

1Cited by

20References

27Claims

0Family size

Assignee

DuPont Industrial Biosciences USA, LLC · US

Inventors

Yougen Li · Pennington, US
Ellen D. Semke · Newark, US
Mark S. Payne · Wilmington, US
Jared B. Parker · Elkton, US
Susan Marie Hennessey · Avondale, US
Slavko Kralj · Copenhagen, DK
Veli Alkan · Palo Alto, US
Richard R. Bott · Burlingame, US

Key dates

Filing date	Sep 11, 2018
Grant date	Sep 15, 2020
Priority date	—
Expiry date	Sep 11, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG16B25/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein are glucosyltransferases with modified amino acid sequences. Such engineered enzymes synthesize alpha-glucan products having increased molecular weight. Further disclosed are reactions and methods in which engineered glucosyltransferases are used to produce alpha-glucan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.